Author: oncologs.com

MIAMI, FLORIDA (May 21, 2024) – A U.S. Food and Drug Administration committee voted unanimously in April to approve a new clinical endpoint, minimal residual disease (MRD), when evaluating proposed drugs to treat multiple myeloma. Credit: Photo by Sylvester MIAMI, FLORIDA (May 21, 2024) –

Hepatocellular carcinoma (HCC), a prevalent form of cancer, profoundly influences the progression and prognosis of the disease through immune response mechanisms. The tumor microenvironment plays a pivotal role in fostering immune suppression and maintaining self-tolerance, which are crucial in developing and refining immunotherapy approaches. Credit:

In a new review paper, Carlo Maley and Arizona State University colleagues describe cell-in-cell phenomena in which one cell engulfs and sometimes consumes another. The study shows that cases of this behavior, including cell cannibalism, are widespread across the tree of life.  Credit: Jason Drees for the

“Despite the potential advantages of utilizing UV-C radiation for deactivating pathogens such as SARS-CoV-2, the prevailing conclusion remains that UV-C radiation poses concurrent risks to human health.” Credit: 2024 Alessio et al. “Despite the potential advantages of utilizing UV-C radiation for deactivating pathogens such as

“Our research findings suggest that miR-377 could potentially serve as a valuable therapeutic strategy for the treatment of prostate cancer (PCa).” Credit: 2024 Azimi et al. “Our research findings suggest that miR-377 could potentially serve as a valuable therapeutic strategy for the treatment of prostate

FOR IMMEDIATE RELEASE Credit: Photo courtesy of Jelani Zarif FOR IMMEDIATE RELEASE A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for

OAK BROOK, Ill. – In a study of nearly 5,000 screening mammograms interpreted by an FDA-approved AI algorithm, patient characteristics such as race and age influenced false positive results. The study’s results were published today in Radiology, a journal of the Radiological Society of North

WARSAW, POLAND [May 21, 2024] — The National Comprehensive Cancer Network® (NCCN®)—a global nonprofit responsible for leading cancer treatment guidelines—is taking part in two events in Warsaw focused on advancing cancer care and highlighting the Poland-US bilateral achievements in health care from May 21-22, 2024.

An exceptional $8 million, 10-year philanthropic investment will spearhead new treatments for pancreatic cancer and create a new dedicated research centre at WEHI. Credit: WEHI An exceptional $8 million, 10-year philanthropic investment will spearhead new treatments for pancreatic cancer and create a new dedicated research

Aging is contributing at the 2024 Systems Aging Gordon Research Conference in Barcelona, Spain, from June 2–7. Credit: Impact Journals Aging is contributing at the 2024 Systems Aging Gordon Research Conference in Barcelona, Spain, from June 2–7. BUFFALO, NY- May 20, 2024 – Aging is